RICE HALL JAMES & ASSOCIATES, LLC — 13F Holdings & Portfolio

CIK 1230765 · latest 13F-HR filed 2026-08-07

RICE HALL JAMES & ASSOCIATES, LLC manages $2.05B in 13F-reported U.S. long-equity assets across 240 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are LGND (4.15%), ACIW (2.46%), ARLO (2.45%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 14 new positions and exited 17; 126 existing positions rose in reported value and 60 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$2.05B

Long-equity book

Holdings
240

Distinct positions

Period
2026-06-30

Filed 2026-08-07

Q/Q Activity
+14 / −17 / ↑126 / ↓60

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 24.1%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated May 6, 2026.

Assets Under Management
$1.74B
Discretionary
$1.74B
Employees
23
Accounts
249
Address
600 WEST BROADWAY SUITE 1000
SAN DIEGO, CA 92101
Phone
(619) 239-9005
Name Title / Status Ownership Type
BUU-HOAN, THUONG-THAO, NGUYEN ControlMANAGING MEMBER, CHIEF OPERATING OFFICER, PRESIDENT
since Jun 2009
10–25%Individual
HOLTZ, LOUIS, MILLETT ControlMANAGING MEMBER, CHIEF INVESTMENT OFFICER, PORTFOLIO MANAGER
since Oct 2018
10–25%Individual
LIPSKER, YOSSEF, YTZHAK ControlMANAGING MEMBER, PORTFOLIO MANAGER
since Oct 2018
10–25%Individual
MARQUEZ, JANINE, ANN ControlCHIEF COMPLIANCE OFFICER
since Jun 2009
Less than 5%Individual
OBECK, CARL, MARTIN ControlMEMBER, CHIEF FINANCIAL OFFICER
since Jun 2009
10–25%Individual
SARGEN, DANIEL, STEVEN ControlMANAGING MEMBER, CHIEF INVESTMENT OFFICER, PORTFOLIO MANAGER
since Jan 2025
5–10%Individual
TODARO, TIMOTHY, ALAN ControlMANAGING MEMBER, PORTFOLIO MANAGER
since Feb 2003
10–25%Individual
RICE, GARY, SCHULERPORTFOLIO MANAGER
since Aug 1987
10–25%Individual
Ownership & leadership changes · 6 filings with changes since Mar 29, 2012

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 26, 2026 filing
  • No longer listedMCDOWELL, THOMAS, W · CHAIRMAN EMERITUS · 10–25% · control person · listed since Jan 2025
  • ChangedSARGEN, DANIEL, STEVEN · now a control person
Mar 28, 2025 filing
  • No longer listedTHOME, CARA, MARGARET · MANAGING MEMBER, PORTFOLIO MANAGER · 10–25% · control person · listed since Jun 2009
  • AddedSARGEN, DANIEL, STEVEN · MANAGING MEMBER, CHIEF INVESTMENT OFFICER, PORTFOLIO MANAGER · 5–10%
  • ChangedHOLTZ, LOUIS, MILLETT · ownership 5–10% → 10–25%
  • ChangedLIPSKER, YOSSEF, YTZHAK · ownership 5–10% → 10–25%
  • ChangedMCDOWELL, THOMAS, W · title MANAGING MEMBER, CHIEF EXECUTIVE OFFICER, CO-CHIEF INVESTMENT OFFICER → CHAIRMAN EMERITUS
  • ChangedOBECK, CARL, MARTIN · ownership 5–10% → 10–25%
Mar 29, 2023 filing
  • ChangedMCDOWELL, THOMAS, W · title MANAGING MEMBER, CHIEF EXECUTIVE OFFICER, CHIEF INVESTMENT OFFICER → MANAGING MEMBER, CHIEF EXECUTIVE OFFICER, CO-CHIEF INVESTMENT OFFICER
Mar 29, 2019 filing
  • AddedHOLTZ, LOUIS, MILLETT · MANAGING MEMBER, CHIEF INVESTMENT OFFICER, PORTFOLIO MANAGER · 5–10% · control person
  • AddedLIPSKER, YOSSEF, YTZHAK · MANAGING MEMBER, PORTFOLIO MANAGER · 5–10% · control person
Mar 30, 2017 filing
  • ChangedMCDOWELL, THOMAS, W · title MANAGING MEMBER, CHIEF EXECUTIVE OFFICER → MANAGING MEMBER, CHIEF EXECUTIVE OFFICER, CHIEF INVESTMENT OFFICER
Aug 8, 2016 filing
  • AddedRICE, GARY, SCHULER · PORTFOLIO MANAGER · 10–25%
  • ChangedMARQUEZ, JANINE, ANN · now a control person
  • ChangedMCDOWELL, THOMAS, W · ownership 25–50% → 10–25%
  • ChangedTHOME, CARA, MARGARET · title MANAGING MEMBER → MANAGING MEMBER, PORTFOLIO MANAGER
  • ChangedTODARO, TIMOTHY, ALAN · title MANAGING MEMBER → MANAGING MEMBER, PORTFOLIO MANAGER
Mar 29, 2012 filing (earliest on record)
  • ListedBUU-HOAN, THUONG-THAO, NGUYEN · MANAGING MEMBER, CHIEF OPERATING OFFICER, PRESIDENT · 10–25% · control person
  • ListedMARQUEZ, JANINE, ANN · CHIEF COMPLIANCE OFFICER · Less than 5%
  • ListedMCDOWELL, THOMAS, W · MANAGING MEMBER, CHIEF EXECUTIVE OFFICER · 25–50% · control person
  • ListedOBECK, CARL, MARTIN · MEMBER, CHIEF FINANCIAL OFFICER · 5–10% · control person
  • ListedTHOME, CARA, MARGARET · MANAGING MEMBER · 10–25% · control person
  • ListedTODARO, TIMOTHY, ALAN · MANAGING MEMBER · 10–25% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

RICE HALL JAMES & ASSOCIATES, LLC Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 LIGAND PHARMACEUTICALS INC LGND 53220K504 $85.4M 4.15% 270,052 SH
2 ACI WORLDWIDE INC ACIW 004498101 $50.6M 2.46% 1,006,595 SH
3 ARLO TECHNOLOGIES INC ARLO 04206A101 $50.3M 2.45% 3,732,962 SH
4 FABRINET FN G3323L100 $49.2M 2.40% 87,577 SH
5 ESTABLISHMENT LABS HLDGS INC ESTA G31249108 $48.1M 2.34% 560,935 SH
6 XPO INC XPO 983793100 $46.2M 2.25% 224,878 SH
7 ZIFF DAVIS INC ZD 48123V102 $43.0M 2.09% 821,496 SH
8 SHIFT4 PMTS INC FOUR 82452J109 $42.5M 2.07% 874,492 SH
9 KINIKSA PHARMACEUTICALS INTL KNSA G52694109 $40.0M 1.95% 624,928 SH
10 ASCENDIS PHARMA A/S ASND K08588103 $39.6M 1.93% 148,644 SH
11 STRIDE INC LRN 86333M108 $37.9M 1.84% 438,981 SH
12 PRESTIGE CONSMR HEALTHCARE I PBH 74112D101 $32.6M 1.59% 689,692 SH
13 DONNELLEY FINL SOLUTIONS INC DFIN 25787G100 $32.5M 1.58% 775,119 SH
14 ITURAN LOCATION AND CONTROL ITRN M6158M104 $29.0M 1.41% 475,496 SH
15 MEDPACE HLDGS INC MEDP 58506Q109 $28.7M 1.39% 54,116 SH
16 ARMSTRONG WORLD INDS INC NEW AWI 04247X102 $28.4M 1.38% 177,147 SH
17 GODADDY INC GDDY 380237107 $28.1M 1.37% 330,474 SH
18 BIRKENSTOCK HOLDING PLC BIRK M2029K104 $27.1M 1.32% 629,868 SH
19 CLEAR SECURE INC YOU 18467V109 $27.0M 1.32% 485,011 SH
20 INGEVITY CORP NGVT 45688C107 $26.2M 1.28% 351,203 SH
21 WEX INC WEX 96208T104 $25.2M 1.23% 178,606 SH
22 SPORTRADAR GROUP AG SRAD H8088L103 $23.9M 1.16% 1,597,682 SH
23 LIQUIDITY SVCS INC LQDT 53635B107 $23.8M 1.16% 608,476 SH
24 FEDERAL AGRIC MTG CORP AGM 313148306 $23.5M 1.15% 118,094 SH
25 BIOCRYST PHARMACEUTICALS INC BCRX 09058V103 $23.3M 1.13% 2,332,043 SH
26 UPWORK INC UPWK 91688F104 $23.2M 1.13% 2,776,805 SH
27 GENPACT LIMITED G G3922B107 $22.9M 1.12% 833,996 SH
28 SUPERNUS PHARMACEUTICALS SUPN 868459108 $22.8M 1.11% 490,221 SH
29 VIRIDIAN THERAPEUTICS INC VRDN 92790C104 $21.6M 1.05% 1,175,906 SH
30 RADWARE LTD RDWR M81873107 $21.0M 1.02% 680,853 SH
31 ALKERMES PLC ALKS G01767105 $20.5M 1.00% 390,866 SH
32 NEXXEN INTL LTD NEXN M8T80P204 $19.7M 0.96% 2,186,838 SH
33 PROGRESS SOFTWARE CORP PRGS 743312100 $19.1M 0.93% 570,261 SH
34 QUIDELORTHO CORP QDEL 219798105 $18.6M 0.91% 1,063,559 SH
35 LEMAITRE VASCULAR INC LMAT 525558201 $18.2M 0.89% 189,907 SH
36 EURONET WORLDWIDE INC EEFT 298736109 $18.1M 0.88% 247,689 SH
37 LKQ CORP LKQ 501889208 $17.9M 0.87% 678,259 SH
38 WIX COM LTD WIX M98068105 $17.4M 0.84% 382,619 SH
39 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $16.9M 0.82% 100,195 SH
40 HARROW INC HROW 415858109 $16.5M 0.80% 387,545 SH
41 OSHKOSH CORP OSK 688239201 $16.3M 0.79% 106,011 SH
42 VAIL RESORTS INC MTN 91879Q109 $15.9M 0.78% 117,085 SH
43 ACADIA PHARMACEUTICALS INC ACAD 004225108 $15.7M 0.76% 618,887 SH
44 LCI INDS LCII 50189K103 $15.1M 0.74% 142,665 SH
45 VAREX IMAGING CORP VREX 92214X106 $15.1M 0.73% 1,445,853 SH
46 MAXIMUS INC MMS 577933104 $15.0M 0.73% 278,910 SH
47 BIOMARIN PHARMACEUTICAL INC BMRN 09061G101 $14.2M 0.69% 248,224 SH
48 TAYSHA GENE THERAPIES INC TSHA 877619106 $13.6M 0.66% 1,992,229 SH
49 BANK OZK LITTLE ROCK ARK OZK 06417N103 $13.5M 0.66% 259,433 SH
50 MIRUM PHARMACEUTICALS INC MIRM 604749101 $13.0M 0.63% 110,673 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-07 $2.05B 240 0001172661-26-003169
2026-03-31 2026-05-15 $1.80B 243 0001172661-26-002239
2025-12-31 2026-02-17 $1.82B 243 0001172661-26-000807
2025-09-30 2025-10-16 $1.83B 248 0001172661-25-004300
Filer Information
Address
600 WEST BROADWAY STE 1000
SAN DIEGO, CA 92101
Phone
(619) 239-9005
Filing Manager
RICE HALL JAMES & ASSOCIATES, LLC
San Diego, CA
Signatory
Janine Marquez
Chief Compliance Officer